https://www.cpa-italy.org/it/news/2026/nerpharma-acquistata-da-un-colosso-farmaceutico-francese.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-gdufa-iv-talks-reach-tentative-agreement-america-first-application-fee-waiver-added.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/usa-a-quality-tax-for-foreign-drug-makers-the-links-between-national-security-trade-deals-and-drug-quality.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/sun-pharma-compra-organon.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/aifa-pubblica-il-terzo-position-paper-sui-farmaci-biosimilari.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/fda-ema-officials-encourage-companies-to-pilot-ectd-40.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/testo-unico-legislazione-farmaceutica-assegnato-alla-x-commissione-senato.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/china-revises-drug-administration-regulations-to-spur-innovation-tighten-oversight.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/aifa-aggiornamento-tariffe-istat-dal-1-aprile-2026.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/aifa-rafforza-il-dialogo-con-gli-stakeholder-approvati-due-nuovi-regolamenti.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/trump-signs-order-imposing-100-tariff-on-patented-pharmaceuticals-ingredients.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/generic-industry-against-giving-fee-breaks-to-firms-setting-up-operations-in-the-us.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/usa-.-la-corte-suprema-boccia-i-dazi-globali-di-trump-cosa-cambia-e-perche-il-pharma-resta-nel-mirino.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/eu-finalizes-pharma-reform-package-clarifies-new-rules-on-modular-market-protection.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/istat-20-import-da-cina-in-2025-farmaceutico-decuplicato-a-77-mld.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/farmaceutica-italiana-export-boom-verso-gli-usa-ma-cresce-la-dipendenza-dalla-cina.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-fda-svolta-storica-bastera-un-solo-studio-registrativo-per-approvare-i-nuovi-farmaci.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/farmaceutica-surplus-ue-a-221-mld-nel-2025-italia-prima-per-import.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/aifa-per-la-prima-volta-i-vertici-in-missione-istituzionale-in-giappone.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-fda-drafts-guidance-on-best-practices-for-responding-to-inspection-observations.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/intelligenza-artificiale-e-salute-le-agenzie-regolatorie-al-centro-della-rivoluzione-farmaceutica.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/tga-clarifies-therapeutic-goods-are-unaffected-by-chemical-production-and-import-ban.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/aifa-aggiornamento-della-nota-esplicativa-relativa-alla-procedura-del-“silenzio-assenso”-in-accordo-con-la-nuova-ec-classification-guideline-sulle-variazioni.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/industry-clamors-for-clearer-guidance-on-transition-to-ich-m4q-r2-.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-fda-announces-the-2026-qmm-prototype-assessment-protocol-evaluation-program.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/aifa-nuova-modalita-multi-beneficiario-per-i-pagamenti-online-delle-tariffe-previste-dal-d.m.-6-dicembre-2016.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-iran-ceasefire-provides-potential-relief-for-pharma-logistics-cost-structures.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/top-drugs-at-risk-of-supply-shortages.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/regulatory-considerations-for-pharmaceutical-excipient-selection.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-qmm-participants-scored-well-on-commitment-to-quality-lower-on-advanced-manufacturing.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/quantum-computing-nelle-life-sciences-a-milano-un-convegno-per-l’industria-farmaceutica.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/edqm-shares-guidance-on-reliance-based-and-fast-track-cep-filings.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-fda-proposes-waiving-gdufa-facility-fees-for-domestic-manufacturers.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/testo-unico-farmaceutica-per-ridurre-la-dipendenza-estera-dai-principi-attivi.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/trump-tariff-order-pushes-onshore-drug-manufacturing-longer-term-analysts.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/pfas-restriction-proposal-echa’s-socio-economic-analysis-committee-agrees-its-draft-opinion.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/farmaci-gemmato-in-cantiere-anche-un-ritorno-nazionale-alla-chimica-farmaceutica-di-base.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/dal-china-all’india-shoring-il-rischio-di-una-nuova-dipendenza.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/nuove-norme-ue-sui-farmaci-piu-incentivi-all’innovazione-e-controllo-della-disponibilita.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/as-iran-war-squeezes-middle-east-drug-shipments-experts-warn-of-longer-term-effects-on-us-manufacturing-generics.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/iran-blocco-hormuz-su-produzione-farmaci-se-dura-ci-sara-impatto-tra-6-mesi-.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/echa’s-risk-assessment-committee-adopts-its-opinion-on-pfas-restriction-proposal.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/computer-software-assurance-for-production-and-quality-management-system-software.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/pharma-expert-discusses-effort-to-standardize-cmc-quality-information.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/ema-outlines-methods-for-evaluating-supply-chain-vulnerabilities.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/ema-management-board-highlights-of-march-2026-meeting.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/farmalabor-investiti-85-milioni-in-un-progetto-per-le-malattie-rare.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/difenderemo-il-farmaco-made-in-italy-sottosegretario-alla-salute-gemmato-dal-payback-alla-dipendenza-da-india-e-cina.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/contract-manufacturing-deals-for-drugs-marketed-in-us-shift-to-europe.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/difendere-il-valore-della-chimica-farmaceutica-nazionale-significa-difendere-il-diritto-alla-salute-del-cittadino-italiano.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/farmaci-salvavita-l’italia-dipende-all’80-da-cina-e-india-gemmato-poche-settimane-di-autonomia-in-caso-di-crisi.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/guerre-e-filiera-vulnerabile-l’industria-farmaceutica-italiana-cerca-le-contromisure.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/sostanze-stupefacenti-il-ministero-aggiorna-le-tabelle-inclusa-la-classe-dei-nitazeni-tra-le-sostanze-vietate.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/gemmato-iran-rschio-carenze-farmaci-legge-delega-per-rafforzare-produzione-nazionale-convochero-tavolo-.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/us-fda-draft-guidance-on-establishing-impurity-specifications-for-antibiotics.html 2026-05-01 0.80 https://www.cpa-italy.org/it/news/2026/alfasigma-cede-a-fine-foods-il-100-di-sofar.html 2026-05-01 0.80